ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Angiopoietin 2 Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-24L9664
Home | Market Reports | Health| Pharmacy
Global Angiopoietin 2 Market Insights Forecast to 2028
BUY CHAPTERS

Global Angiopoietin 2 Market Research Report 2025

Code: QYRE-Auto-24L9664
Report
January 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
AnGes MG Inc
Boehringer Ingelheim GmbH
Eli Lilly and Company
F Hoffmann La Roche Ltd
MedImmune
Regeneron Pharmaceuticals Inc
RXi Pharmaceuticals Corporation
Silence Therapeutics Plc
Synergys Biotherapeutics, Inc.

Angiopoietin 2 Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Angiopoietin 2 Market

Angiopoietin 2 Market

The global market for Angiopoietin 2 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Angiopoietin 2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiopoietin 2.
The Angiopoietin 2 market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Angiopoietin 2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angiopoietin 2 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Angiopoietin 2 Market Report

Report Metric Details
Report Name Angiopoietin 2 Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • Atu-111
  • BI-836880
  • LY-3127804
  • MEDI-3617
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amgen Inc., AnGes MG, Inc., Boehringer Ingelheim GmbH, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., MedImmune, LLC, Regeneron Pharmaceuticals, Inc., RXi Pharmaceuticals Corporation, Silence Therapeutics Plc, Synergys Biotherapeutics, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Angiopoietin 2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Angiopoietin 2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Angiopoietin 2 Market report?

Ans: The main players in the Angiopoietin 2 Market are Amgen Inc., AnGes MG, Inc., Boehringer Ingelheim GmbH, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., MedImmune, LLC, Regeneron Pharmaceuticals, Inc., RXi Pharmaceuticals Corporation, Silence Therapeutics Plc, Synergys Biotherapeutics, Inc.

What are the Application segmentation covered in the Angiopoietin 2 Market report?

Ans: The Applications covered in the Angiopoietin 2 Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Angiopoietin 2 Market report?

Ans: The Types covered in the Angiopoietin 2 Market report are Atu-111, BI-836880, LY-3127804, MEDI-3617, Others

Recommended Reports

Blood Collection & Transfusion

Vascular Devices & Grafts

Imaging & Angioplasty Solutions

1 Angiopoietin 2 Market Overview
1.1 Product Definition
1.2 Angiopoietin 2 by Type
1.2.1 Global Angiopoietin 2 Market Value Comparison by Type (2024 VS 2031)
1.2.2 Atu-111
1.2.3 BI-836880
1.2.4 LY-3127804
1.2.5 MEDI-3617
1.2.6 Others
1.3 Angiopoietin 2 by Application
1.3.1 Global Angiopoietin 2 Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Angiopoietin 2 Market Size Estimates and Forecasts
1.4.1 Global Angiopoietin 2 Revenue 2020-2031
1.4.2 Global Angiopoietin 2 Sales 2020-2031
1.4.3 Global Angiopoietin 2 Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Angiopoietin 2 Market Competition by Manufacturers
2.1 Global Angiopoietin 2 Sales Market Share by Manufacturers (2020-2025)
2.2 Global Angiopoietin 2 Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Angiopoietin 2 Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Angiopoietin 2, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Angiopoietin 2, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Angiopoietin 2, Product Type & Application
2.7 Global Key Manufacturers of Angiopoietin 2, Date of Enter into This Industry
2.8 Global Angiopoietin 2 Market Competitive Situation and Trends
2.8.1 Global Angiopoietin 2 Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Angiopoietin 2 Players Market Share by Revenue
2.8.3 Global Angiopoietin 2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Angiopoietin 2 Market Scenario by Region
3.1 Global Angiopoietin 2 Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Angiopoietin 2 Sales by Region: 2020-2031
3.2.1 Global Angiopoietin 2 Sales by Region: 2020-2025
3.2.2 Global Angiopoietin 2 Sales by Region: 2026-2031
3.3 Global Angiopoietin 2 Revenue by Region: 2020-2031
3.3.1 Global Angiopoietin 2 Revenue by Region: 2020-2025
3.3.2 Global Angiopoietin 2 Revenue by Region: 2026-2031
3.4 North America Angiopoietin 2 Market Facts & Figures by Country
3.4.1 North America Angiopoietin 2 Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Angiopoietin 2 Sales by Country (2020-2031)
3.4.3 North America Angiopoietin 2 Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Angiopoietin 2 Market Facts & Figures by Country
3.5.1 Europe Angiopoietin 2 Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Angiopoietin 2 Sales by Country (2020-2031)
3.5.3 Europe Angiopoietin 2 Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Angiopoietin 2 Market Facts & Figures by Region
3.6.1 Asia Pacific Angiopoietin 2 Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Angiopoietin 2 Sales by Region (2020-2031)
3.6.3 Asia Pacific Angiopoietin 2 Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Angiopoietin 2 Market Facts & Figures by Country
3.7.1 Latin America Angiopoietin 2 Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Angiopoietin 2 Sales by Country (2020-2031)
3.7.3 Latin America Angiopoietin 2 Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Angiopoietin 2 Market Facts & Figures by Country
3.8.1 Middle East and Africa Angiopoietin 2 Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Angiopoietin 2 Sales by Country (2020-2031)
3.8.3 Middle East and Africa Angiopoietin 2 Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Angiopoietin 2 Sales by Type (2020-2031)
4.1.1 Global Angiopoietin 2 Sales by Type (2020-2025)
4.1.2 Global Angiopoietin 2 Sales by Type (2026-2031)
4.1.3 Global Angiopoietin 2 Sales Market Share by Type (2020-2031)
4.2 Global Angiopoietin 2 Revenue by Type (2020-2031)
4.2.1 Global Angiopoietin 2 Revenue by Type (2020-2025)
4.2.2 Global Angiopoietin 2 Revenue by Type (2026-2031)
4.2.3 Global Angiopoietin 2 Revenue Market Share by Type (2020-2031)
4.3 Global Angiopoietin 2 Price by Type (2020-2031)
5 Segment by Application
5.1 Global Angiopoietin 2 Sales by Application (2020-2031)
5.1.1 Global Angiopoietin 2 Sales by Application (2020-2025)
5.1.2 Global Angiopoietin 2 Sales by Application (2026-2031)
5.1.3 Global Angiopoietin 2 Sales Market Share by Application (2020-2031)
5.2 Global Angiopoietin 2 Revenue by Application (2020-2031)
5.2.1 Global Angiopoietin 2 Revenue by Application (2020-2025)
5.2.2 Global Angiopoietin 2 Revenue by Application (2026-2031)
5.2.3 Global Angiopoietin 2 Revenue Market Share by Application (2020-2031)
5.3 Global Angiopoietin 2 Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Amgen Inc.
6.1.1 Amgen Inc. Company Information
6.1.2 Amgen Inc. Description and Business Overview
6.1.3 Amgen Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amgen Inc. Angiopoietin 2 Product Portfolio
6.1.5 Amgen Inc. Recent Developments/Updates
6.2 AnGes MG, Inc.
6.2.1 AnGes MG, Inc. Company Information
6.2.2 AnGes MG, Inc. Description and Business Overview
6.2.3 AnGes MG, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AnGes MG, Inc. Angiopoietin 2 Product Portfolio
6.2.5 AnGes MG, Inc. Recent Developments/Updates
6.3 Boehringer Ingelheim GmbH
6.3.1 Boehringer Ingelheim GmbH Company Information
6.3.2 Boehringer Ingelheim GmbH Description and Business Overview
6.3.3 Boehringer Ingelheim GmbH Angiopoietin 2 Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boehringer Ingelheim GmbH Angiopoietin 2 Product Portfolio
6.3.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.4 Eli Lilly and Company
6.4.1 Eli Lilly and Company Company Information
6.4.2 Eli Lilly and Company Description and Business Overview
6.4.3 Eli Lilly and Company Angiopoietin 2 Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Eli Lilly and Company Angiopoietin 2 Product Portfolio
6.4.5 Eli Lilly and Company Recent Developments/Updates
6.5 F. Hoffmann-La Roche Ltd.
6.5.1 F. Hoffmann-La Roche Ltd. Company Information
6.5.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.5.3 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales, Revenue and Gross Margin (2020-2025)
6.5.4 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product Portfolio
6.5.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.6 MedImmune, LLC
6.6.1 MedImmune, LLC Company Information
6.6.2 MedImmune, LLC Description and Business Overview
6.6.3 MedImmune, LLC Angiopoietin 2 Sales, Revenue and Gross Margin (2020-2025)
6.6.4 MedImmune, LLC Angiopoietin 2 Product Portfolio
6.6.5 MedImmune, LLC Recent Developments/Updates
6.7 Regeneron Pharmaceuticals, Inc.
6.7.1 Regeneron Pharmaceuticals, Inc. Company Information
6.7.2 Regeneron Pharmaceuticals, Inc. Description and Business Overview
6.7.3 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product Portfolio
6.7.5 Regeneron Pharmaceuticals, Inc. Recent Developments/Updates
6.8 RXi Pharmaceuticals Corporation
6.8.1 RXi Pharmaceuticals Corporation Company Information
6.8.2 RXi Pharmaceuticals Corporation Description and Business Overview
6.8.3 RXi Pharmaceuticals Corporation Angiopoietin 2 Sales, Revenue and Gross Margin (2020-2025)
6.8.4 RXi Pharmaceuticals Corporation Angiopoietin 2 Product Portfolio
6.8.5 RXi Pharmaceuticals Corporation Recent Developments/Updates
6.9 Silence Therapeutics Plc
6.9.1 Silence Therapeutics Plc Company Information
6.9.2 Silence Therapeutics Plc Description and Business Overview
6.9.3 Silence Therapeutics Plc Angiopoietin 2 Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Silence Therapeutics Plc Angiopoietin 2 Product Portfolio
6.9.5 Silence Therapeutics Plc Recent Developments/Updates
6.10 Synergys Biotherapeutics, Inc.
6.10.1 Synergys Biotherapeutics, Inc. Company Information
6.10.2 Synergys Biotherapeutics, Inc. Description and Business Overview
6.10.3 Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Synergys Biotherapeutics, Inc. Angiopoietin 2 Product Portfolio
6.10.5 Synergys Biotherapeutics, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Angiopoietin 2 Industry Chain Analysis
7.2 Angiopoietin 2 Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Angiopoietin 2 Production Mode & Process Analysis
7.4 Angiopoietin 2 Sales and Marketing
7.4.1 Angiopoietin 2 Sales Channels
7.4.2 Angiopoietin 2 Distributors
7.5 Angiopoietin 2 Customer Analysis
8 Angiopoietin 2 Market Dynamics
8.1 Angiopoietin 2 Industry Trends
8.2 Angiopoietin 2 Market Drivers
8.3 Angiopoietin 2 Market Challenges
8.4 Angiopoietin 2 Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Amgen Inc
AnGes MG Inc
Boehringer Ingelheim GmbH
Eli Lilly and Company
F Hoffmann La Roche Ltd
MedImmune
Regeneron Pharmaceuticals Inc
RXi Pharmaceuticals Corporation
Silence Therapeutics Plc
Synergys Biotherapeutics, Inc.
List of Tables
 Table 1. Global Angiopoietin 2 Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Angiopoietin 2 Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Angiopoietin 2 Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Angiopoietin 2 Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Angiopoietin 2 Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Angiopoietin 2 Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Angiopoietin 2 Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Angiopoietin 2 Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Angiopoietin 2, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Angiopoietin 2, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Angiopoietin 2, Product Type & Application
 Table 12. Global Key Manufacturers of Angiopoietin 2, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Angiopoietin 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiopoietin 2 as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Angiopoietin 2 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Angiopoietin 2 Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Angiopoietin 2 Sales Market Share by Region (2020-2025)
 Table 19. Global Angiopoietin 2 Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Angiopoietin 2 Sales Market Share by Region (2026-2031)
 Table 21. Global Angiopoietin 2 Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Angiopoietin 2 Revenue Market Share by Region (2020-2025)
 Table 23. Global Angiopoietin 2 Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Angiopoietin 2 Revenue Market Share by Region (2026-2031)
 Table 25. North America Angiopoietin 2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Angiopoietin 2 Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Angiopoietin 2 Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Angiopoietin 2 Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Angiopoietin 2 Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Angiopoietin 2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Angiopoietin 2 Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Angiopoietin 2 Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Angiopoietin 2 Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Angiopoietin 2 Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Angiopoietin 2 Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Angiopoietin 2 Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Angiopoietin 2 Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Angiopoietin 2 Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Angiopoietin 2 Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Angiopoietin 2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Angiopoietin 2 Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Angiopoietin 2 Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Angiopoietin 2 Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Angiopoietin 2 Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Angiopoietin 2 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Angiopoietin 2 Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Angiopoietin 2 Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Angiopoietin 2 Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Angiopoietin 2 Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Angiopoietin 2 Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Angiopoietin 2 Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Angiopoietin 2 Sales Market Share by Type (2020-2025)
 Table 53. Global Angiopoietin 2 Sales Market Share by Type (2026-2031)
 Table 54. Global Angiopoietin 2 Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Angiopoietin 2 Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Angiopoietin 2 Revenue Market Share by Type (2020-2025)
 Table 57. Global Angiopoietin 2 Revenue Market Share by Type (2026-2031)
 Table 58. Global Angiopoietin 2 Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Angiopoietin 2 Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Angiopoietin 2 Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Angiopoietin 2 Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Angiopoietin 2 Sales Market Share by Application (2020-2025)
 Table 63. Global Angiopoietin 2 Sales Market Share by Application (2026-2031)
 Table 64. Global Angiopoietin 2 Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Angiopoietin 2 Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Angiopoietin 2 Revenue Market Share by Application (2020-2025)
 Table 67. Global Angiopoietin 2 Revenue Market Share by Application (2026-2031)
 Table 68. Global Angiopoietin 2 Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Angiopoietin 2 Price (USD/Pcs) by Application (2026-2031)
 Table 70. Amgen Inc. Company Information
 Table 71. Amgen Inc. Description and Business Overview
 Table 72. Amgen Inc. Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Amgen Inc. Angiopoietin 2 Product
 Table 74. Amgen Inc. Recent Developments/Updates
 Table 75. AnGes MG, Inc. Company Information
 Table 76. AnGes MG, Inc. Description and Business Overview
 Table 77. AnGes MG, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. AnGes MG, Inc. Angiopoietin 2 Product
 Table 79. AnGes MG, Inc. Recent Developments/Updates
 Table 80. Boehringer Ingelheim GmbH Company Information
 Table 81. Boehringer Ingelheim GmbH Description and Business Overview
 Table 82. Boehringer Ingelheim GmbH Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Boehringer Ingelheim GmbH Angiopoietin 2 Product
 Table 84. Boehringer Ingelheim GmbH Recent Developments/Updates
 Table 85. Eli Lilly and Company Company Information
 Table 86. Eli Lilly and Company Description and Business Overview
 Table 87. Eli Lilly and Company Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Eli Lilly and Company Angiopoietin 2 Product
 Table 89. Eli Lilly and Company Recent Developments/Updates
 Table 90. F. Hoffmann-La Roche Ltd. Company Information
 Table 91. F. Hoffmann-La Roche Ltd. Description and Business Overview
 Table 92. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product
 Table 94. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
 Table 95. MedImmune, LLC Company Information
 Table 96. MedImmune, LLC Description and Business Overview
 Table 97. MedImmune, LLC Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. MedImmune, LLC Angiopoietin 2 Product
 Table 99. MedImmune, LLC Recent Developments/Updates
 Table 100. Regeneron Pharmaceuticals, Inc. Company Information
 Table 101. Regeneron Pharmaceuticals, Inc. Description and Business Overview
 Table 102. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product
 Table 104. Regeneron Pharmaceuticals, Inc. Recent Developments/Updates
 Table 105. RXi Pharmaceuticals Corporation Company Information
 Table 106. RXi Pharmaceuticals Corporation Description and Business Overview
 Table 107. RXi Pharmaceuticals Corporation Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. RXi Pharmaceuticals Corporation Angiopoietin 2 Product
 Table 109. RXi Pharmaceuticals Corporation Recent Developments/Updates
 Table 110. Silence Therapeutics Plc Company Information
 Table 111. Silence Therapeutics Plc Description and Business Overview
 Table 112. Silence Therapeutics Plc Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Silence Therapeutics Plc Angiopoietin 2 Product
 Table 114. Silence Therapeutics Plc Recent Developments/Updates
 Table 115. Synergys Biotherapeutics, Inc. Company Information
 Table 116. Synergys Biotherapeutics, Inc. Description and Business Overview
 Table 117. Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Synergys Biotherapeutics, Inc. Angiopoietin 2 Product
 Table 119. Synergys Biotherapeutics, Inc. Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Angiopoietin 2 Distributors List
 Table 123. Angiopoietin 2 Customers List
 Table 124. Angiopoietin 2 Market Trends
 Table 125. Angiopoietin 2 Market Drivers
 Table 126. Angiopoietin 2 Market Challenges
 Table 127. Angiopoietin 2 Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Angiopoietin 2
 Figure 2. Global Angiopoietin 2 Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Angiopoietin 2 Market Share by Type: 2024 & 2031
 Figure 4. Atu-111 Product Picture
 Figure 5. BI-836880 Product Picture
 Figure 6. LY-3127804 Product Picture
 Figure 7. MEDI-3617 Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Angiopoietin 2 Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Angiopoietin 2 Market Share by Application: 2024 & 2031
 Figure 11. Hospital
 Figure 12. Clinic
 Figure 13. Others
 Figure 14. Global Angiopoietin 2 Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Angiopoietin 2 Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Angiopoietin 2 Sales (2020-2031) & (K Pcs)
 Figure 17. Global Angiopoietin 2 Average Price (USD/Pcs) & (2020-2031)
 Figure 18. Angiopoietin 2 Report Years Considered
 Figure 19. Angiopoietin 2 Sales Share by Manufacturers in 2024
 Figure 20. Global Angiopoietin 2 Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Angiopoietin 2 Players: Market Share by Revenue in Angiopoietin 2 in 2024
 Figure 22. Angiopoietin 2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Angiopoietin 2 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Angiopoietin 2 Sales Market Share by Country (2020-2031)
 Figure 25. North America Angiopoietin 2 Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Angiopoietin 2 Sales Market Share by Country (2020-2031)
 Figure 29. Europe Angiopoietin 2 Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Angiopoietin 2 Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Angiopoietin 2 Revenue Market Share by Region (2020-2031)
 Figure 37. China Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Angiopoietin 2 Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Angiopoietin 2 Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Angiopoietin 2 Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Angiopoietin 2 Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Angiopoietin 2 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Angiopoietin 2 by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Angiopoietin 2 by Type (2020-2031)
 Figure 59. Global Angiopoietin 2 Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Angiopoietin 2 by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Angiopoietin 2 by Application (2020-2031)
 Figure 62. Global Angiopoietin 2 Price (USD/Pcs) by Application (2020-2031)
 Figure 63. Angiopoietin 2 Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Angiopoietin 1 Receptor Market Research Report 2024
Global Antiangiogenic Agent Market Research Report 2025
Global Angiographic Interventional Therapy System Market Research Report 2025
Global Angio Seal Devices Market Research Report 2025
Global Angiography System Equipment Market Research Report 2025
Global Angiography Tubing Market Research Report 2025
Angiocatheter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Angiography Machine Market Research Report 2025
Global Vascular Interventional Apparatus Market Insights Forecast to 2030
Global Peripheral Vascular Guide Wire Market Research Report 2025
Global Cancer Angiogenesis Inhibitors Market Research Report 2024
Global Vascular Interventional Robot Market Research Report 2025
Global Interventional Cardiovascular Device Market Research Report 2025
Global Medical Angiography Devices Market Insights Forecast to 2030
Hematopoietic Progenitor Cells Transplantation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Angiography Imaging Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemodialysis Vascular Graft Market Insights Forecast to 2030
VEGF Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cerebral Angiography Market Research Report 2024
Global Vascular Allografts Market Research Report 2025

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions